Skip to content
Equity.Guru Equity.Guru

Investment information for millennials and madmen

  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
Saturday, Dec 14, 2019
Equity.Guru Equity.Guru

Investment information for millennials and madmen

Primary Menu
  • Who we are
    • The EG Capital Markets Program
    • The Equity.Guru FAQ
    • Are you guys pumpers?
    • Contact Us
  • Podcast
  • Resources
  • Cannabis
  • Education
  • Tearsheets
  • Newsletter
Wednesday December 11, 2019

Explore Our Pages

  • Home
  • Who we are
    • EG Capital Markets Program
    • Equity.Guru FAQ
    • Are you guys pumpers?
    • Contact Us
  • Podcasts
  • Resources
  • Cannabis
  • Education
  • Tearsheets
  • Newsletter
  • Home
  • Health-Medicine
  • Pharmaceuticals

Pharmaceuticals

Amgen (AMGN.Q) gets a new facility to continue doing Gods work against cancer

Joseph Morton
December 11, 2019
Amgen (AMGN.Q) signed a lease with BioMed Realty for a new 240,000 square foot Leadership in Energy and Environmental Design (LEED) candidate facility in the Gateway of Pacific campus development in south San Francisco earlier this week.

Merck (MRK.NASDAQ), Sanofi (SNY.NASDQ) – is Big Pharma a cancer?

Lukas Kane
December 9, 2019
December 9, 2019 – “Merger Monday” –  a couple of Big Pharma companies announced plans to acquire two cancer-focused biotechs – in separate deals worth a combined $5.2 billion.

Karuna Therapeutics (KRTX.Q) is not the biotech play for the faint-hearted

Special Contributor
November 20, 2019
When markets closed Friday November 15, Karuna Therapeutics (KRTX.Q) was just another pharma-stock trading in the mid-teens trying to make drugs for patients with Alzheimer’s and Schizophrenia.

Johnson & Johnson (JNJ.NYSE) issues recall for asbestos laden baby powder, and none are surprised

Joseph Morton
October 18, 2019
Johnson & Johnson (JNJ.NYSE) issued a recall for a single lot of its Baby Powder in response to a FDA test that uncovered the presence of sub-trace levels (no greater than 0.00002%) of chrysotile asbestos contamination in samples from a single bottle purchased from an online retailer.

Regeneron Pharmaceuticals’ (REGN.Q) Dupixent one step closer to providing relief to sufferers

Joseph Morton
September 20, 2019
My best friend growing up married a woman with severe rhinosinusitis and nasal polyps. That sounds about as serious as a case of the common cold and a bad headache, but there were many lost nights where my friend and his wife required an ER visit to get her breathing again.

Investing is a trip and we hope you’re along for the ride – Mushroom Madness

Ethan Reyes
September 18, 2019
Cannabis has been good to us here at equity.guru. There are 1,283 pages of cannabis-related content on our site and it’s still growing.

Cambridge House’s XFuture event spearheads brave new world of psychedelic treatments

Ethan Reyes
September 18, 2019
Last minute attendees can register for Cambridge House’s Extraordinary Future event here and use promocode: FUTURE30 for 30% off.

A ‘growing’ concern: With the cannabis bubble bursting, are mushrooms the next gold rush?

Ethan Reyes
August 30, 2019
“Cannabis is dead; long live cannabis.” Mushrooms, mark my words..

China raises the specter of evil cannabis to deflect away from its role in opioid crisis

Joseph Morton
August 28, 2019
China has a bug up its ass about U.S. and Canada’s new permissive cannabis laws.

Johnson & Johnson (JNJ.NYSE) is to pay $572 million as finger-pointing gets under way in opioid epidemic

Joseph Morton
August 26, 2019
An Oklahoma district court judge has ordered Johnson & Johnson (JNJ.NYSE) to pay $572 million for its part in the state’s opioid epidemic.

Regen Biopharma (RGBP.OTC) gets 180% bump for cancer-fighting patent

Joseph Morton
August 7, 2019
We all know someone who’s been touched by cancer.

GW Pharma (GWPH.Q) gets recommendation on cannabis-derived epilepsy drug

Ethan Reyes
July 26, 2019
GW Pharmaceuticals (GWPH.Q) has received a recommendation from the European Medicines Agency (EMA) for the authorization of the company’s Epidyolex cannabis oral solution for use in the treatment of seizures.

Posts navigation

1 2 … 6 Next

Podcast

  • Popular
  • Recent
  • Comment

MedMen (MMEN.C): cannabis catastrophe – 5 red flags everyone should have seen

Lukas Kane
November 29, 2019

Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it

Chris Parry
December 12, 2019

Why did Canopy (WEED.T) Aurora (ACB.T) and Aphria (APHA.T) gain $10 million per minute today?

Lukas Kane
November 21, 2019

The U.S. Fed and market liquidity or welcome to the everything bubble

Gaalen Engen
December 13, 2019

Silicon Valley virtual assistants are always on and always listening

Joseph Morton
December 13, 2019

Defense Metals (DEN.V) tags 4.01% LREO over 58 meters – locked and loaded for 2020

Greg Nolan
December 13, 2019
  • Chris Parry  on  Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it
  • Kevin  on  Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it
  • Dave Brice  on  Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it
  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
© Equity Guru Media Inc 2019, All rights reserved.
A list of current marketing clients can be found here
✖

Cancel reply

Cancel